Domestic pharmaceutical industry likely to lose momentum over rebate ban

Published: 2009-08-04 06:59:00
Updated: 2009-08-04 06:59:00
Korean firms’ generic drugs are expected to lose steam once the government cracks down on pharmaceutical firms offering rebates starting August.

Experts said domestic manufacturers can no longer expect to live off of selling copied drugs, as hospitals will probably choose to prescribe original...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.